Selektive retina-therapie bei patienten mit diabetischer makulopathie

Translated title of the contribution: Selective retina therapy in patients with diabetic maculopathy

H. Elsner*, C. Klatt, S. H.M. Liew, E. Pörksen, A. Bunse, M. Rudolf, R. Brinkmann, R. P. Hamilton, R. Birngruber, H. Laqua, J. Roider

*Corresponding author for this work
19 Citations (Scopus)


Selective Retina Therapy (SRT) is a new laser treatment that selectively targets the retinal pigmen epithelium (RPE). In this study, we treated 39 patients presenting with nonischemic, focal and focal-diffuse diabetic maculopathy with SRT. In the main. the results indicate that SRT had stabilizing effects on visual acuity, angiographic leakage, lipid exudation, and foveal retinal thickness. SRT is safe and is especially useful for treating pathologies that are located close to the fovea, which cannot be treated with conventional argon laser photocoagulation.

Translated title of the contributionSelective retina therapy in patients with diabetic maculopathy
Original languageGerman
Issue number10
Pages (from-to)856-860
Number of pages5
Publication statusPublished - 10.2006

Research Areas and Centers

  • Academic Focus: Biomedical Engineering


Dive into the research topics of 'Selective retina therapy in patients with diabetic maculopathy'. Together they form a unique fingerprint.

Cite this